Empagliflozin, a part of Loncom Pharma's Antidiabetic Drugs, is a key player in diabetes management. It effectively controls blood sugar levels, enhancing the well-being of diabetic patients.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
